Literature DB >> 7967344

Fluid and solute transport in CAPD patients using ultralow sodium dialysate.

A L Imholz1, G C Koomen, D G Struijk, L Arisz, R T Krediet.   

Abstract

Transcapillary ultrafiltration during CAPD is determined by the ultrafiltration coefficient of the peritoneal membrane and by Starling forces, the latter being mainly determined by the osmolality of the dialysate. Dialysate sodium concentration decreases during a dwell, implying that: (1) sodium passes the peritoneal membrane to a lesser extent than H2O, and (2) more H2O than sodium is removed in overhydrated patients. We therefore compared two dialysate solutions with similar osmolality, but different sodium concentration (Na+ 129 mmol/liter and 102 mmol/liter). Two peritoneal permeability tests (2 x 6 hrs, dextran 70 as volume marker) with an interval of two days were performed in 10 CAPD patients. Transcapillary ultrafiltration rate was higher with ultralow sodium dialysate (USD) than normal sodium dialysate (NSD): 1.80 +/- 0.16 ml/min versus 1.58 +/- 0.18 (P < 0.01). It was especially higher during the last two hours of the dwell: 0.49 +/- 0.12 ml/min (USD) versus 0.27 +/- 0.13 (NSD). The effective lymphatic absorption rate was not different: 1.01 +/- 0.12 ml/min (USD) versus 1.05 +/- 0.09 (NSD). Using two different kinetic models, the reflection coefficients for glucose, sodium and chloride were 0.032, 0.029 and 0.027 (for the convection model) and 0.033, 0.030 and 0.027 (for the diffusion model). As a consequence the decline in osmotic pressure was more gradual during the exchange with USD. The peritoneal membrane characteristics, that is the effective peritoneal surface area and the peritoneal restriction coefficient, were not altered by the composition of the dialysate.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7967344     DOI: 10.1038/ki.1994.279

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

1.  Celiac disease and lymphoma risk: a multicentric case--control study in Spain.

Authors:  Carme Farré; Eva Domingo-Domenech; Rebeca Font; Teresa Marques; Alberto Fernandez de Sevilla; Tomas Alvaro; Mercedes Garcia Villanueva; Vicens Romagosa; Silvia de Sanjose
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

2.  Course of encephalopathy in a cirrhotic dialysis patient treated sequentially with peritoneal and hemodialysis.

Authors:  Suleyman Koz; Idris Sahin; Zafer Terzi; Sema Tulay Koz
Journal:  Case Rep Med       Date:  2015-03-25

3.  Future technologies and techniques in peritoneal dialysis-opportunities and challenges ahead.

Authors:  Clifford J Holmes; Watske Smit
Journal:  NDT Plus       Date:  2008-10

Review 4.  Volume-Independent Sodium Toxicity in Peritoneal Dialysis: New Insights from Bench to Bed.

Authors:  Silvio Borrelli; Luca De Nicola; Ilaria De Gregorio; Lucio Polese; Luigi Pennino; Claudia Elefante; Alessandro Carbone; Tiziana Rappa; Roberto Minutolo; Carlo Garofalo
Journal:  Int J Mol Sci       Date:  2021-11-26       Impact factor: 5.923

5.  Peritoneal function in clinical practice: the importance of follow-up and its measurement in patients. Recommendations for patient information and measurement of peritoneal function.

Authors:  Annemieke M Coester; Watske Smit; Dirk G Struijk; Raymond T Krediet
Journal:  NDT Plus       Date:  2009-01-15

6.  The effects of low-sodium peritoneal dialysis fluids on blood pressure, thirst and volume status.

Authors:  Simon Davies; Ola Carlsson; Ole Simonsen; Ann-Cathrine Johansson; Daniele Venturoli; Ingrid Ledebo; Anders Wieslander; Cian Chan; Bengt Rippe
Journal:  Nephrol Dial Transplant       Date:  2009-01-14       Impact factor: 5.992

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.